CERS logo

CERS
Cerus Corp.

4,437
Mkt Cap
$538.99M
Volume
1.18M
52W High
$3.15
52W Low
$1.15
PE Ratio
-54.12
CERS Fundamentals
Price
$2.77
Prev Close
$2.69
Open
$2.65
50D MA
$2.07
Beta
1.96
Avg. Volume
1M
EPS (Annual)
-$0.082
P/B
7.98
Rev/Employee
$749,574.55
$407.43
Loading...
Loading...
News
all
press releases
Vivek Jayaraman Sells 16,667 Shares of Cerus (NASDAQ:CERS) Stock
Cerus Corporation (NASDAQ:CERS - Get Free Report) COO Vivek Jayaraman sold 16,667 shares of Cerus stock in a transaction that occurred on Friday, May 1st. The shares were sold at an average price of...
MarketBeat·16d ago
News Placeholder
More News
News Placeholder
Cerus (NASDAQ:CERS) Sees Unusually-High Trading Volume Following Analyst Upgrade
Cerus (NASDAQ:CERS) Sees Strong Trading Volume Following Analyst Upgrade...
MarketBeat·17d ago
News Placeholder
Top 3 Health Care Stocks That May Collapse This Month
Stocks AVNS, APLS, and CERS in healthcare sector flashing warning to momentum-sensitive investors. High RSI values & price action indicate overbought conditions. AVNS at 90. APLS at 86. CERS at 86...
Benzinga·17d ago
News Placeholder
Cerus (NASDAQ:CERS) Upgraded by Zacks Research to Hold Rating
Zacks Research raised shares of Cerus from a "strong sell" rating to a "hold" rating in a research note on Thursday...
MarketBeat·19d ago
News Placeholder
Cerus (NASDAQ:CERS) Upgraded by Wall Street Zen to Buy Rating
Wall Street Zen raised shares of Cerus from a 'hold' rating to a 'buy' rating in a report on Saturday...
MarketBeat·20d ago
News Placeholder
Cerus (NASDAQ:CERS) Reaches New 12-Month High After Better-Than-Expected Earnings
Cerus (NASDAQ:CERS) Reaches New 12-Month High on Better-Than-Expected Earnings...
MarketBeat·20d ago
News Placeholder
BTIG Research Upgrades Cerus (NASDAQ:CERS) to "Buy"
BTIG Research upgraded Cerus from a "neutral" rating to a "buy" rating and set a $4.00 price objective for the company in a research note on Friday...
MarketBeat·20d ago
News Placeholder
Cerus (NASDAQ:CERS) Issues Quarterly Earnings Results, Beats Estimates By $0.02 EPS
Cerus (NASDAQ:CERS - Get Free Report) released its quarterly earnings data on Thursday. The biotechnology company reported ($0.01) earnings per share for the quarter, topping the consensus estimate...
MarketBeat·21d ago
News Placeholder
Cerus (CERS) Q1 2026 Earnings Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets·21d ago
News Placeholder
Cerus Q1 Earnings Call Highlights
Cerus (NASDAQ:CERS) reported first-quarter 2026 product revenue of $53.7 million, up 24% from the prior-year period, as management pointed to continued strength in its global INTERCEPT platelet franchise and accelerating demand for its INTERCEPT Fibrinogen Complex (IFC) business in the United States...
MarketBeat·21d ago
<
1
2
...
>

Latest CERS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.